Durability of Boosted Atazanavir (ATV) or Darunavir (DRV) Plus Maraviroc (MVC) Dual rescue Therapy in Poorly Adherent Subjects in View of Long-Acting Drugs

Amedeo F Capetti^1*, Noemi Astuti¹, Simona Landonio¹, Fosca P Niero¹, Stefania Vimercati², Gianfranco Dedivitiis¹ and Giuliano Rizzardini^1,3

¹1^st Division of Infectious Diseases, Luigi Sacco Hospital, 20157 Milano, Italy, E-mail: Noemi.astuti@lhsacco.it

²Pharmacy Unit, Luigi Sacco Hospital, 20157 Milano, Italy, E-mail: Noemi.astuti@lhsacco.it

³Whitwaterstrand University, 2050 Johannesburg, South Africa, E-mail: Noemi.astuti@lhsacco.it

^*Corresponding Author: Amedeo F Capetti, Via Giovanni Battista Grassi, 74, 20157 Milano, Ospedale ‘Luigi Sacco’, Pad. 56, Piano 2°, Italy, Tel: 393478436579, Fax: 390239042568 Email: